Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noelle P Dahl

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Virology|October 21, 2011
Latent HIV-1 infection of resting CD4⁺ T cells in the humanized Rag2⁻/⁻ γc⁻/⁻ mouseShailesh K Choudhary, Nancie M Archin, Manzoor Cheema, et al.
Molecular Therapy. Methods & Clinical Development|September 16, 2025
HLA-A2 CAR/IL-2-CISC engineered Treg display robust <i>in vitro</i> and <i>in vivo</i> antigen-specific regulatory functionSubhash K Tripathi, Annaiz Grimm, Noelle P Dahl, et al.
Journal of Virology|September 26, 2014
Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cellsNatalia Soriano-Sarabia, Rosalie E Bateson, Noelle P Dahl, et al.
Plos Pathogens|October 17, 2015
Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV InfectionNatalia Soriano-Sarabia, Nancie M Archin, Rosalie Bateson, et al.
The Journal of Infectious Diseases|April 17, 2015
Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication StrategiesAmanda M Crooks, Rosalie Bateson, Anna B Cope, et al.
Future Medicinal Chemistry|July 2, 2015
Gold nanoparticles to improve HIV drug deliveryCarolina Garrido, Carrie A Simpson, Noelle P Dahl, et al.
Contemporary Topics in Laboratory Animal Science|September 27, 2003
The effect of an environmental enrichment device on individually caged rabbits in a safety assessment facilityColena A Johnson, Wendi A Pallozzi, Leann Geiger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 28, 2024
Blunting specific T-dependent antibody responses with engineered "decoy" B cellsRagan A Pitner, Jaime L Chao, Noelle P Dahl, et al.
Science Translational Medicine|April 10, 2024
BCR signaling is required for posttransplant lymphoproliferative disease in immunodeficient mice receiving human B cellsTing-Ting Zhang, Rene Yu-Hong Cheng, Andee R Ott, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 6, 2023
A chemically inducible IL-2 receptor signaling complex allows for effective in vitro and in vivo selection of engineered CD4+ T cellsPeter J Cook, Su Jung Yang, Gene I Uenishi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Virology|October 21, 2011
Latent HIV-1 infection of resting CD4⁺ T cells in the humanized Rag2⁻/⁻ γc⁻/⁻ mouseShailesh K Choudhary, Nancie M Archin, Manzoor Cheema, et al.
Molecular Therapy. Methods & Clinical Development|September 16, 2025
HLA-A2 CAR/IL-2-CISC engineered Treg display robust <i>in vitro</i> and <i>in vivo</i> antigen-specific regulatory functionSubhash K Tripathi, Annaiz Grimm, Noelle P Dahl, et al.
Journal of Virology|September 26, 2014
Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cellsNatalia Soriano-Sarabia, Rosalie E Bateson, Noelle P Dahl, et al.
Plos Pathogens|October 17, 2015
Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV InfectionNatalia Soriano-Sarabia, Nancie M Archin, Rosalie Bateson, et al.
The Journal of Infectious Diseases|April 17, 2015
Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication StrategiesAmanda M Crooks, Rosalie Bateson, Anna B Cope, et al.
Future Medicinal Chemistry|July 2, 2015
Gold nanoparticles to improve HIV drug deliveryCarolina Garrido, Carrie A Simpson, Noelle P Dahl, et al.
Contemporary Topics in Laboratory Animal Science|September 27, 2003
The effect of an environmental enrichment device on individually caged rabbits in a safety assessment facilityColena A Johnson, Wendi A Pallozzi, Leann Geiger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 28, 2024
Blunting specific T-dependent antibody responses with engineered "decoy" B cellsRagan A Pitner, Jaime L Chao, Noelle P Dahl, et al.
Science Translational Medicine|April 10, 2024
BCR signaling is required for posttransplant lymphoproliferative disease in immunodeficient mice receiving human B cellsTing-Ting Zhang, Rene Yu-Hong Cheng, Andee R Ott, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 6, 2023
A chemically inducible IL-2 receptor signaling complex allows for effective in vitro and in vivo selection of engineered CD4+ T cellsPeter J Cook, Su Jung Yang, Gene I Uenishi, et al.
Pageof 2